Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Jagiellońskie Centrum Innowacji (JCI) was established in 2004 by the Jagiellonian University in Kraków, Poland. The organization focuses on building and managing infrastructure for the Life Science Park, providing a wide range of services for entrepreneurs and scientists in the life sciences sector. Initially, from 2009 to 2013, JCI primarily offered laboratory space rental, grant projects, and financial support for companies through the JCI Venture fund. Since 2013, JCI has expanded its offerings to include contract research services and clinical trials conducted at its specialized Clinical Research Center.
As of now, JCI has made investments in 16 startups, totaling 11.6 million PLN. The organization has analyzed 400 project applications, showcasing its active role in the startup ecosystem. JCI operates a specialized Clinical Research Center, enhancing its capabilities in conducting clinical trials. The firm is headquartered at the Life Science Park in Kraków, Poland, and continues to evolve its services to meet the needs of the life sciences sector.
JCI invests in and provides services related to life sciences, including pharmaceuticals, medical devices, cosmetics, and food supplements. Their investment strategy encompasses early-stage startups, specifically targeting the pre-seed, seed, and seed+ (extension) stages. JCI's check sizes are tailored to support these early ventures effectively. The firm emphasizes an integrated approach, offering not only funding through the JCI Venture fund but also essential services such as contract research and clinical trials.
Additionally, JCI supports early-stage startups through programs like KRK InnoTech Starter (KITS), a pre-accelerator program aimed at fostering innovative business ventures in life sciences. This program provides startups with the necessary resources and guidance to navigate the complexities of the life sciences industry, enhancing their chances of success.
Paweł Błachno - CEO, President of the Board. He has extensive experience in managing innovation projects and leading teams in the life sciences sector.
Marek Bartosz, MBA - Member of the Board. He brings a wealth of knowledge in business management and strategic planning.
Aneta Kuczkowicz, MBA - Director of Legal and Administrative Department. She oversees legal compliance and administrative functions.
Rafał Szkaradek, MBA - Director of Infrastructure Department. He is responsible for managing the infrastructure of the Life Science Park.
dr Piotr Wardęga - Director of Development Department. He focuses on strategic development and partnerships.
Aleksandra Piotrowska, MBA - Director of Production Department. She manages production processes and quality assurance.
Aleksandra Król - Director of JCI Kindergarten. She oversees educational initiatives within the organization.
Katarzyna Bętkowska - Director of Clinical Research Center. She leads clinical research initiatives and trials.
dr Jolanta Kaleta - Director of Quality Department. She ensures quality standards are met across all operations.
Dominika Kustosz - Director of Marketing and PR Department. She manages marketing strategies and public relations.
Anna Sikora - Financial Director. She oversees financial management and investment strategies.
Startups should pitch to JCI via email at jci@jci.pl. It is important to include a comprehensive deck that outlines the business model, team, and market opportunity. JCI typically responds within a few weeks of receiving a pitch.
JCI runs the KRK InnoTech Starter (KITS), a pre-accelerator program designed to support innovative business ventures in the life sciences sector. This program provides startups with mentorship, resources, and guidance to help them develop their business ideas and prepare for future funding opportunities.
What are JCI's investment criteria?
JCI focuses on early-stage startups in the life sciences sector, including pharmaceuticals, medical devices, cosmetics, and food supplements. They look for innovative business models and strong founding teams.
How can startups apply or pitch to JCI?
Startups can pitch to JCI by sending an email to jci@jci.pl. It is advisable to include a detailed business plan and information about the team and product.
What makes JCI different from other investors?
JCI combines funding with essential services such as contract research and clinical trials, providing a unique support structure for life sciences startups.
What is JCI's geographic scope?
JCI primarily invests in startups located in Europe, focusing on the life sciences sector.
What is JCI's post-investment involvement like?
JCI is actively involved with its portfolio companies, offering operational support and access to their Clinical Research Center for conducting trials.
What is the typical fund size or check size for JCI?
JCI's total investment amount is 11.6 million PLN, with check sizes tailored to the needs of early-stage startups.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.